Genzyme develops heart gene therapy products:
This article was originally published in Clinica
Executive Summary
Genzyme General, the drugs, diagnostics and instruments company, is expanding its research into gene therapy products for blocked coronary and peripheral arteries. Two deals have been signed with St Elizabeth's Medical Center in Boston and Johns Hopkins University School of Medicine in Baltimore to develop treatments for restenosis and growing new vessels.